Insider NameBuy/SellCompany NameTickerAmountShares Change
Feb 13, 2025Feb 14, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$116.85$298,908-1.80%
Feb 10, 2025Feb 12, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$118.39$116,020-0.71%
Jan 31, 2025Feb 04, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$152.87$235,577-1.11%
Jan 15, 2025Jan 17, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$141.5$9M-32.44%
Feb 13, 2024Feb 15, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$132.9$179,674-0.99%
Feb 06, 2024Feb 09, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$139.16$359,041-1.89%
Jan 31, 2024Feb 03, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$140.7$216,813-1.16%
Jan 02, 2024Jan 04, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$131.47$10M-36.54%
Aug 21, 2023Aug 24, 2023Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$107.41$228,993-1.61%
Feb 06, 2023Feb 09, 2023Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$102.8$2M-11.72%
Jan 31, 2023Feb 02, 2023Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$109.99$169,486-1.35%
Feb 07, 2022Feb 09, 2022Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$80.61$554,628-5.83%
Jan 05, 2022Jan 07, 2022Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$85.5$2M-21.21%
Feb 05, 2021Feb 10, 2021Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$115.65$736,702-5.73%
Nov 12, 2020Nov 16, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$90.73$204,770-2.25%
Aug 05, 2020Aug 07, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$118.87$268,286-2.30%
Apr 24, 2020Apr 29, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$99.47$192,377-2.02%
Feb 07, 2020Feb 12, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$103.33$167,710-1.73%
Feb 05, 2020Feb 07, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$102.7$481,675-4.93%
Feb 06, 2019Feb 08, 2019Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$83.56$63,673-0.88%
Feb 04, 2019Feb 06, 2019Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$88.12$335,668-4.30%
Aug 01, 2018Aug 03, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$115$3M-26.41%
Mar 05, 2018Mar 07, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$90$2M-23.10%
Feb 05, 2018Feb 07, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$83.05$169,914-2.51%
Jan 16, 2018Jan 18, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$79.05$128,460-2.12%
Nov 02, 2017Nov 06, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$71.05$2M-25.31%
Sep 06, 2017Oct 03, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$60$1M-21.78%
Sep 06, 2017Sep 08, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$60$276,420-5.92%
May 01, 2017May 03, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$54$810,000-17.00%
Apr 12, 2017Apr 13, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$50.42$658,774-15.14%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.